Clinical study on the administration before ABO incompatible kidney transplantation

Clinical study on the administration before ABO incompatible kidney transplantation - Clinical study on the administration before ABO incompatible kidney transplantation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006613

Enrollment

Registered

2011-11-01

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ABO incompatible kidney transplantation

Interventions

administration of retuximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who will be given ABO incompatible renal transprantation

Exclusion criteria

Exclusion criteria: the patients who dose not hope for transplantation previous treatment by adminstration of rituximab

Design outcomes

Primary

Measure	Time frame
graft survival	—

Secondary

Measure	Time frame
presence of the immunological rejection onset	—

Countries

Japan

Contacts

Public ContactKunihisa Yamaguchi

University of Tokushima Urology

kunihisa-y@clin.med.tokushima-u.ac.jp088-633-7159

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026